Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weber

Showing results (841-850 of 880) with videos related to

Pageof 88
Sort By:
Leukemia|January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study GroupN Jahn, M Agrawal, L Bullinger, et al.
Nucleic Acids Research|March 15, 2019
Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disordersBrooke E Hjelm, Brandi Rollins, Ling Morgan, et al.
Science (New York, N.Y.)|January 23, 2025
Mechanically robust and stretchable organic solar cells plasticized by small-molecule acceptorsZhenye Wang, Di Zhang, Lvpeng Yang, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis SensitivityChe-Pei Kung, Nick D Terzich, Ma Xenia G Ilagen, et al.
Leukemia|February 1, 2017
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureM Wattad, D Weber, K Döhner, et al.
Leukemia|June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaV I Gaidzik, D Weber, P Paschka, et al.
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Leukemia|November 3, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Leukemia|May 4, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 12, 2018
Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid ModulatorsJason R Clapper, Cassandra L Henry, Micah J Niphakis, et al.
Pageof 88

Showing results (841-850 of 880) with videos related to

Sort By:
Pageof 88
Leukemia|January 17, 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study GroupN Jahn, M Agrawal, L Bullinger, et al.
Nucleic Acids Research|March 15, 2019
Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disordersBrooke E Hjelm, Brandi Rollins, Ling Morgan, et al.
Science (New York, N.Y.)|January 23, 2025
Mechanically robust and stretchable organic solar cells plasticized by small-molecule acceptorsZhenye Wang, Di Zhang, Lvpeng Yang, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis SensitivityChe-Pei Kung, Nick D Terzich, Ma Xenia G Ilagen, et al.
Leukemia|February 1, 2017
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureM Wattad, D Weber, K Döhner, et al.
Leukemia|June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaV I Gaidzik, D Weber, P Paschka, et al.
Journal of Medicinal Chemistry|June 8, 2000
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structuresD R Bolin, A L Swain, R Sarabu, et al.
Leukemia|November 3, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
Leukemia|May 4, 2016
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresV I Gaidzik, V Teleanu, E Papaemmanuil, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 12, 2018
Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid ModulatorsJason R Clapper, Cassandra L Henry, Micah J Niphakis, et al.
Pageof 88